Proton magnetic resonance spectroscopy: An emerging technology in pediatric neurology research

Pediatric Research

Volumn 44, Issue 1, 1998, Pages 1-10

  Novotny, Edward ^a   Ashwal, Stephen ^b   Shevell, Michael ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INJURY; BRAIN METABOLISM; CLINICAL RESEARCH; COMPUTER PROGRAM; EPILEPTIC FOCUS; HUMAN; INFANT; INTRACTABLE EPILEPSY; NEAR DROWNING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL ASPHYXIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

EID: 0031813923     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199807000-00001     Document Type: Review

References (94)

1. Aria Tzika A 1995 Localized MR spectroscopy of neurodegeneration disease and tumors. In: Farber EN (ed) CNS Magnetic Resonance Imaging in Infants and Children. McKeith Press, London, pp 307-328
2. Beall PT, Amtey SR, Kasturi SR 1984 NMR Data Handbook for Biomedical Applications. Pergamon Press, New York, pp 170-180
3. Sanders JKM, Hunter BK 1987 Modem NMR Spectroscopy: A Guide for Chemists. Oxford University Press, Oxford, pp 138-162
4. Tofts PS, Wray S 1988 A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy. NMR Biomed 1:1-10
5. DeRome AE 1987 Modern NMR Techniques for Chemistry Research. Pergamon Press, Oxford, pp 85-96
6. Ordidge RJ, Bowley RM, McHale G 1988 A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn Reson Med 8:323-331
7. Maudsley AA, Lin E, Weiner MW 1992 Spectroscopic imaging display and analysis. Magn Reson Imaging 10:471-485
8. 1H spectroscopic imaging at high spatial resolution. NMR Biomed 2:234-239
9. 1H NMR spectra of human brain. Magn Reson Med 32:294-302
10. 1H NMR difference spectra of the human brain. Magn Reson Med 27:183-188
11. 1H NMR spectra of glutamate in the human brain. Magn Reson Med 25:94-106
12. 1H NMR spectroscopy in patients with chronic hepatic encephalopathy. Analysis of changes in cerebral glutamine, choline and inositols. NMR Biomed 4:109-116
13. 1H NMR measurements of γ-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 90:5662-5666
14. Michaelis T, Helms G, Merboldt KD, Hanicke W, Bruhn H, Frahm J 1993 Identification of scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed 6:105-109
15. Novotny Jr EJ, Avison MJ, Herschkowitz N, Petroff OA, Prichard JW, Seashore MR, Rothman DL 1995 In vivo measurement of phenylalanine in human brain by proton nuclear magnetic resonance spectroscopy. Pediatr Res 37:244-249
16. Hanstock CC, Rothman DL, Shulman RG, Novotny Jr EJ, Petroff OA, Prichard JW 1990 Measurement of ethanol in the human brain using NMR spectroscopy. J Stud Alcohol 51:104-107
17. Cady EB, Lorek A, Penrice J, Reynolds EO, Iles RA, Burns SP, Coutts GA, Cowan FM 1994 Detection of propan- 1,2-diol in neonatal brain by in vivo proton magnetic resonance spectroscopy. Magn Reson Med 32:764-767
18. Kreis R, Ernst T, Ross BD 1993 Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30:424-437
19. Provencher SW 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
20. Hetherington HP, Mason GF, Pan JW, Ponder SL, Vaughan JT, Twieg DB, Pohost GM 1994 Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1 T. Magn Reson Med 32:565-571
21. van der Knapp MS, van der Grond J, van Rijen PC, Faber JAJ, Valk J, Willemse K 1990 Age dependant changes in localized proton phosphorous MR spectroscopy of the brain. Radiology 176:509-515
22. Kreis R, Ernst T, Ross BD 1993 Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Mag Res Med 30:424-437
23. Huppi PS, Fusch C, Boesch C, Burri R, Bossi E, Amato M, Herschkowitz N 1995 Regional metabolic assessment of human brain during development by proton magnetic resonance spectroscopy in vivo and by high-performance liquid chromatography/gas chromatography in autopsy tissue. Pediatr Res 37:145-150
24. Peden CJ, Cowen FR, Bryant DJ, Sargentoni J, Cox IJ, Menon DK, Gedian DG, Bell JD, Abowitz LM 1990 Proton MR spectroscopy of the brain in infants. J Comput Assist Tomogr 14:886-894
25. Peden CJ, Rutherford MA, Sargentoni J, Cox U, Bryant DJ, Dubowitz LM 1993 Proton spectroscopy of the neonatal brain following hypoxic-ischemic injury. Dev Med Child Neurol 35:502-510
26. Groenendaal F, Veenhoven RH, van der Grond J, Jansen GH, Witkamp TD, de Vries LS 1994 Cerebral lactate and N-acetyl-aspartate/choline ratios in asphyxiated full-term neonates demonstrated in vivo using proton magnetic resonance spectroscopy. Pediatr Res 35:148-151
27. Ross B, Michaelis T 1994 Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 10:191-247
28. 1H magnetic resonance spectroscopy. Invest Radiol 30:502-506
29. Lanfermann H, Kugel H, Heidel W, Herholz K, Heiss WD, Lackner K 1995 Metabolic changes in acute and subacute cerebral infarctions: findings at proton MR spectroscopic imaging. Radiology 196:203-210
30. Murata T, Itoh S, Koshino Y, Omori M, Murata I, Sakamoto K, Isaki K, Kimura H, Ishii Y 1995 Serial proton magnetic resonance spectroscopy in a patient with the interval form of carbon monoxide poisoning. J Neurol Neurosurg Psychiatry 58:100-103
31. Berek K, Lechleitner P, Luef G, Felber S, Saltuari L, Schinnerl A, Traweger C, Dienstl F, Aichner F 1995 Early determination of neurological outcome after pre-hospital cardiopulmonary resuscitation. Stroke 26:543-549
32. Graham GD, Blamire AM, Rothman DL, Brass LM, Fayad PB, Petroff OA, Prichard JW 1993 Early temporal variation of cerebral metabolites after human stroke. A proton magnetic resonance spectroscopy study. Stroke 24:1891-1896
33. Holshouser BA, Ashwal S, Luh GY, Shu S, Kahlon S, Auld KL, Tomasi LG, Perkin RM, Hinshaw Jr DB 1997 Proton MR spectroscopy after acute CNS injury: outcome prediction in neonates, infants and children. Radiology 202:487-496
34. 1H-magnetic resonance spectroscopy. Metabolic changes and their prognostic value. J Clin Invest 97:1142-1154
35. 1H-MRS determined cerebral lactate is associated with poor neurologic outcomes in children with CNS disease. Ann Neurol 41:470-481
36. 1H-NMR spectroscopy. Pediatr Neurosurg 22:81-87
37. Hanrahan JD, Sargentoni J, Azzopardi D, Manji K, Cowan FM, Rutherford MA, Cox IJ, Bell JD, Bryant DJ, Edwards AD 1996 Cerebral metabolism within 18 hours of birth asphyxia: a proton magnetic resonance spectroscopy study. Pediatr Res 39:584-590
38. Penrice J, Cady EB, Lorek A, Wylezinska M, Amess PN, Aldridge RF, Stewart A, Wyatt JS, Reynolds EOR 1996 Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes after perinatal hypoxiaischemia. Pediatr Res 40:6-14
39. Shu S, Ashwal S, Holshouser BA, Nystrom G, Hinshaw Jr DB 1997 Prognostic value of proton magnetic resonance spectroscopy in perinatal nervous system insults. Pediatr Neurol 17:309-318
40. Cross JH, Gadian DG, Connelly A, Leonard JV 1993 Proton magnetic resonance spectroscopy studies in lactic acidosis and mitochondrial disorders. J Inherit Metab Dis 16:800-811
41. Bergman AJ, Van der Knapp MS, Smeitink JA, Duran M, Dorland L, Valk J, Poll-The BT 1996 Magnetic resonance imaging and spectroscopy of the brain in propionic acidemia: Clinical and biochemical considerations. Pediatr Res 40:404-409
42. Shevell MI, Didomenicantonio G, Sylvain M, Arnold DI, O'Gorman AM, Scriver CR 1995 Glutaric acidemia type II: neuroimaging and spectroscopy evidence for developmental encephalomyopathy. Pediatr Neurol 12:350-353
43. Sylvain M, Mitchell GA, Shevell MI, Morin C, Robinson B, DeBraekeleer M, Arnold DL 1993 Muscle and brain magnetic resonance spectroscopy (MRS) and imaging (MRI) in children with Leigh's syndrome associated with cytochrome c oxidase deficiency: dependence of findings on clinical status. Ann Neurol 34:464
44. Harada M, Tanouchi M, Arai K, Nishitani H, Miyoshi H, Hashimoto T 1996 Therapeutic efficacy of a case of pyruvate dehydrogenase complex deficiency monitored by localized proton magnetic resonance spectroscopy. Magn Reson Imag 14:129-133
45. Lorak AK, Penrice JM, Cady EB, Leonard JV, Wyatt JS, Iles RA, Burns SP, Reynolds EO 1996 Cerebral energy metabolism in isovaleric acidaemia. Arch Dis Child 74:F211-213
46. Shevell MI, Matthews PM, Scriver CR, Brown RM, Otero L, Legris M, Brown GK, Arnold DL 1994 Cerebral dysgenesis and lactic acidemia with reduced muscle phosphorylation potential: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency. Pediatr Neurol 11:224-229
47. Hanefeld F, Holzbach U, Kruse B, Wilichowski E, Christen HJ, Frahm J 1993 Diffuse white matter disease in three children: an encephalopathy with unique features on magnetic resonance imaging and proton magnetic resonance spectroscopy. Neuropediatrics 24:244-248
48. Grodd W, Kragelh-Mann I, Peterson D, Trefz FK, Harzer K 1990 In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336:437-438
49. Heindel W, Kugel H, Wendel U, Roth B, Benz-Bohm G 1995 Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol 25:296-299
50. 1H magnetic resonance spectroscopy. J Magn Reson B 107:242-251
51. 1H magnetic resonance spectroscopy. Pediatr Res 38:657-663
52. Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ 1995 Localised proton magnetic resonance spectroscopy in X-linked adenoleukodystrophy. Neuroradiology 37:568-575
53. Korenke GC, Pouwels PJ, Frahm J, Hunneman DH, Stoeckler S, Krasemann E, Jost W, Hanefeld F 1996 Arrested cerebral adrenoleukodystrophy: a clinical and proton magnetic resonance spectroscopy study in three patients. Pediatr Neurol 15:103-107
54. Sylvain M, Arnold DL, Scriver CR, Schreiber R, Shevell MI 1994 Magnetic resonance spectroscopy in Niemann-Pick disease type C: correlation with diagnosis and clinical response to treatment with cholestyramine and lovastatin. Pediatr Neurol 10:228-232
55. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, Scholmerich J, Feuerbach S, Holstege A 1997 Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 25:48-54
56. Pujol J, Kulisevsky J, Moreno A, Deus J, Alonso J, Balanzo J, Marit-Vilalta JL, Capdevila A 1996 Neurospectroscopic alterations and globus pallidus hyperintensity as related magnetic resonance markers of reversible hepatic encephalopathy. Neurology 47:1526-1530
57. Kreis R, Pfenninger J, Herschkowitz N, Boesch C 1995 In vivo proton magnetic resonance spectroscopy in a case of Reye's Syndrome. Intensive Care Med 21:266-269
58. Matthews PM, Andermann F, Arnold DL 1990 A proton magnetic resonance spectroscopy study of focal epilepsy in humans. Neurology 40:985-989
59. Cendes F, Andermann F, Dubeau F, Arnold DL 1995 Proton magnetic resonance spectroscopic images and MRI volumetric studies for lateralization of temporal lobe epilepsy. Magn Reson Imaging 13:1187-1195
60. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG 1994 Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology 44:1411-1417
61. Hetherington HP, Kuzniecky RI, Pan JW, Vaughan JT, Twieg DB, Pohost GM 1995 Application of high field spectroscopic imaging in the evaluation of temporal lobe epilepsy. Magn Reson Imaging 13:1175-1180
62. Ng TC, Comair YG, Xue M, So N, Majors A, Kolem H, Luders H, Modic M 1994 Temporal lobe epilepsy: presurgical localization with proton chemical shift imaging. Radiology 193:465-472
63. Hugg JW, Laxer KD, Matson GB, Maudsley AA, Weiner MW 1993 Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 34:788-794
64. Petroff OA, Spencer DD, Alger JR, Prichard JW 1989 High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 39:1197-1202
65. 1H NMR spectra of human brain in vivo. NMR Biomed 4:90-98
66. Kreis R, Ernst T, Ross BD 1993 Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 30:424-437
67. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH 1996 The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 39:95-99
68. Petroff OA, Rothman DL, Behar KL, Collins TL, Mattson RH 1996 Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 47-1567-1571
69. Petroff OA, Rothman DL, Behar KL, Mattson RH 1996 Low brain GABA level is associated with poor seizure control. Ann Neurol 40:908-911
70. Perry TL, Hansen S 1981 Amino acid abnormalities in epileptogenic foci. Neurology 31:872-876
71. Novotny EJ, Rothman DL, Assaf B 1996 Cerebral amino acid levels in childhood genetic epilepsies. Neurology 46(suppl):A166-167
72. 1H NMR Studies of glucose transport in the human brain. J Cereb Blood Flow Metab 16:427-438
73. 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc Natl Acad Sci USA 90:9896-9900
74. 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci USA 88:5829-5831
75. Mathews PM, Andermann F, Silver K, Karpati G, Arnold DL 1993 Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies. Neurology 43:2484-2490
76. De Stefano N, Matthews PM, Ford B, Genge A, Karpati G, Arnold DL 1995 Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45:1193-1198
77. Petroff OA, Behar KL, Mattson RH, Rothman DL 1996 Human brain γ-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy. J Neurochem 67:2399-2404
78. Arnold DL, Riess GT, Matthews PM, Francis GS, Collins DL, Wolfson C, Antel JP 1994 Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36:76-82
79. Luyten PR, Marien AJ, Heindel W, van Gerwen PH, Herholz K, den Hollander JA, Friedmann G, Heiss WD 1990 Metabolic imaging of patients with intracranial tumors: H-1 MR spectroscopic imaging and PET. Radiology 176:791-799
80. Preul MC, Caramanos Z, Collins DL, Villemure JG, Leblanc R, Olivier A, Pokrupa R, Arnold DL 1996 Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2:323-325
81. 13C]glutamate turnover in human brain. Proc Natl Acad Sci USA 89:9603-9606
82. Mason GF, Gruetter R, Rothman DL, Behar KL, Shulman RG, Novotny EJ 1995 Simultaneous determination of the rates of the TCA cycle, glucose utilization, α-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J Cereb Blood Flow Metab 15:12-25
83. 1H magnetic resonance spectroscopy study. NMR Biomed 1:20-26
84. 1H MRS. Magn Reson Med 30:18-27
85. Pan JW, Vaughan JT, Kuzniecky RI, Pohost GM, Hetherington HP 1995 High resolution neuroimaging at 4.1 T. Magn Reson Imaging 13:915-921
86. Kuzniecky RI 1996 Neuroimaging in pediatric epilepsy. Epilepsia 37(suppl 1):S10-S21
87. Mason GF, Pan JW, Ponder SL, Twieg DB, Pohost GM, Hetherington HP 1994 Detection of brain glutamate and glutamine in spectroscopic images at 4.1 T. Magn Reson Med 32:142-145
88. Pan JW, Mason GF, Pohost GM, Hetherington HP 1996 Spectroscopic imaging of human brain glutamate by water-suppressed J-refocused coherence transfer at 4.1 T. Magn Reson Med 36:7-12
89. Hinke RM, Hu X, Stillman AE, Kim SG, Merkle H, Salmi R, Ugurbil K 1993 Functional magnetic resonance imaging of Broca's area during internal speech. Neuroreport 4:675-678
90. Blamire AM, Ogawa S, Ugurbil K, Rothman D, McCarthy G, Ellermann JM, Hyder F, Rattner Z, Shulman RG 1992 Dynamic mapping of the human visual cortex by high-speed magnetic resonance imaging. Proc Natl Acad Sci USA 89:11069-11073
91. Kim SG, Ashe J, Georgopoulos AP, Merkle H, Ellermann JM, Menon RS, Ogawa S, Ugurbil K 1993 Functional imaging of human motor cortex at high magnetic field. J Neurophysiol 69:297-302
92. LeBihan D, Kami A 1995 Applications of magnetic resonance imaging to the study of human brain function. Curr Opin Neurobiol 5:231-237
93. Kwong KK 1995 Functional magnetic resonance imaging with echo planar imaging. Magn Reson Q 11:1-20
94. Kim SG, Ugurbil K 1997 Functional magnetic resonance imaging of the human brain. J Neurosci Methods 74:229-243